Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone High-Dose vs Standard Fluzone in Elderly
NCT00391053Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Primary completion
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Oct 2006; status: completed.
02
Drugs
trivalent inactivated influenza vaccine high-dose
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00391053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391053.